Potential for Drug-Drug Interactions between Antiretrovirals and HCV Direct Acting Antivirals in a Large Cohort of HIV/HCV Coinfected Patients.
Development of direct acting antivirals (DAA) offers new benefits for patients with chronic hepatitis C. The combination of these drugs with antiretroviral treatment (cART) is a real challenge in HIV/HCV coinfected patients. The aim of this study was to describe potential drug-drug interactions betw...
Main Authors: | Isabelle Poizot-Martin, Alissa Naqvi, Véronique Obry-Roguet, Marc-Antoine Valantin, Lise Cuzin, Eric Billaud, Antoine Cheret, David Rey, Christine Jacomet, Claudine Duvivier, Pascal Pugliese, Pierre Pradat, Laurent Cotte, Hepadat'AIDS Study Group |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4619009?pdf=render |
Similar Items
-
Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination
by: Victor Virlogeux, et al.
Published: (2017-12-01) -
Hepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors but not antiretrovirals
by: Martinez Valrie, et al.
Published: (2012-07-01) -
Molecular epidemiology of HCV monoinfection and HIV/HCV coinfection in injection drug users in Liuzhou, Southern China.
by: Yi Tan, et al.
Published: (2008-01-01) -
Consistency of spatial dynamics of HIV-1 and HCV among HIV-1/HCV coinfected drug users in China
by: Yu Wang, et al.
Published: (2021-09-01) -
Pharmacologic management of HCV treatment in patients with HCV monoinfection vs. HIV/HCV coinfection: Does coinfection really matter?
by: Autumn D Zuckerman, et al.
Published: (2019-01-01)